InvestorsHub Logo
Post# of 175215
Next 10

SC8

Followers 15
Posts 5086
Boards Moderated 0
Alias Born 10/31/2019

SC8

Re: anderson800 post# 147214

Tuesday, 05/24/2022 11:39:58 AM

Tuesday, May 24, 2022 11:39:58 AM

Post# of 175215
Agreed. Buyout might occur on positive human trial data vs. competitive treatments alone. Either way, it would be long after IDE approval. Upon IDE approval, RDGL has to peddle another offering to fund trials (which should close very quickly), pay Mayo to design trial, Mayo has to recruit patients, conduct trail, etc.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News